Free Trial

Health Catalyst (HCAT) Earnings Date, Estimates & Call Transcripts

Health Catalyst logo
$3.98 +0.08 (+2.05%)
As of 04:00 PM Eastern

Health Catalyst Earnings Summary

Upcoming Q4
Earnings Date
May. 7Before Market OpensEstimated
Consensus EPS
(Nov. 6)
$0.10
Actual EPS
(Nov. 6)
$0.07 Missed By -$0.03
Actual Revenue
(Nov. 6)
$76.40M

Health Catalyst posted Q3 2024 earnings on November 6, 2024, reporting an EPS of $0.07, which missed the consensus estimate of $0.10 by $0.03. Quarterly revenue rose 3.5% year-over-year to $76.40 million, above analysts' expectations of $76.27 million. With a trailing EPS of -$1.15, Health Catalyst's earnings are expected to grow next year, from ($0.33) to ($0.29) per share.

Q3 2024 Earnings Resources

HCAT Upcoming Earnings

Health Catalyst's Q1 2025 earnings is scheduled for Wednesday, May 7, 2025, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Health Catalyst Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Health Catalyst and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

HCAT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HCAT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Health Catalyst Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.33) EPS
Next Year EPS Consensus Estimate
($0.29) EPS

Health Catalyst Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2025
(Estimated)
-------
11/6/2024Q3 2024$0.10$0.07 -$0.03$0.06$76.27M$76.40M
8/7/2024Q2 2024$0.08$0.12+$0.04$0.17$74.96M$75.90M
5/9/2024Q1 2024-$0.19-$0.14+$0.05$0.07$74.81M$74.72M
2/22/2024Q4 2023-$0.27-$0.21+$0.06$0.11$73.67M$75.08M
11/2/2023Q3 2023-$0.27-$0.22+$0.05-$0.05$72.73M$73.77M
8/8/2023Q2 2023-$0.30-$0.21+$0.09$0.16$72.67M$73.21M
5/9/2023Q1 2023-$0.34-$0.20+$0.14$0.20$71.16M$73.87M

Health Catalyst Earnings - Frequently Asked Questions

Health Catalyst has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based off last year's report dates. Learn more on HCAT's earnings history.

Health Catalyst issued an update on its first quarter 2025 earnings guidance on Wednesday, February, 26th. The company issued revenue guidance of $79.0 million-$79.0 million, compared to the consensus revenue estimate of $81.9 million.

In the previous quarter, Health Catalyst (NASDAQ:HCAT) missed the analysts' consensus estimate of $0.10 by $0.03 with a reported earnings per share (EPS) of $0.07. Learn more on analysts' earnings estimate vs. HCAT's actual earnings.

The conference call for Health Catalyst's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Health Catalyst's latest earnings report can be read online.
Read Transcript

Health Catalyst (NASDAQ:HCAT) has a recorded annual revenue of $306.58 million.

Health Catalyst (NASDAQ:HCAT) has a recorded net income of -$118.15 million. HCAT has generated -$1.15 earnings per share over the last four quarters.

Health Catalyst's earnings are expected to grow from ($0.33) per share to ($0.29) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:HCAT) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners